%0 Figure %A O. Richards, Frank %A Eigege, Abel %A S. Miri, Emmanuel %A Kal, Alphonsus %A Umaru, John %A Pam, Davou %A J. Rakers, Lindsay %A Sambo, Yohanna %A Danboyi, Jacob %A Ibrahim, Bako %A E. Adelamo, Solomon %A Ogah, Gladys %A Goshit, Danjuma %A Kehinde Oyenekan, O. %A Mathieu, Els %A Craig Withers, P. %A A. Saka, Yisa %A Jiya, Jonathan %A R. Hopkins, Donald %D 2013 %T Age-specific prevalence for mf or LF antigen in Dokan Tofa and Piapung sentinel villages. %U https://plos.figshare.com/articles/figure/_Age_specific_prevalence_for_mf_or_LF_antigen_in_Dokan_Tofa_and_Piapung_sentinel_villages_/396500 %R 10.1371/journal.pntd.0001346.g007 %2 https://ndownloader.figshare.com/files/726180 %K prevalence %K mf %K lf %K antigen %K dokan %K tofa %K piapung %K sentinel %X

Panel A: Dokan Tofa pretreatment prevalence by age group (n = 418). Panel B: Piapung pretreatment prevalence by age group (n = 400). Panel C: Dokan Tofa prevalence by age group after 6 rounds of MDA (n = 223). Panel D: Piapung prevalence by age group after 6 rounds of MDA (n = 280). Boxes show numbers sampled in each age group. Pretreatment sample for mf is different from Table 2 because ages were not available on all persons tested. Pretreatment sample for antigen for these SVs are different than baseline figure shown in Table 3 because 1999/2000 mapping data were added to baseline calculation in Table 3 (see Methods).

%I PLOS Neglected Tropical Diseases